Dr. Medhat Osman
Claim this profileSaint Louis University
Affiliated Hospitals
Saint Louis University
St. Louis University
Clinical Trials Medhat Osman is currently running
Lutetium (177Lu) Vipivotide Tetraxetan
for Prostate Cancer
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to their primary tumor. The data generated from this study will provide evidence for the treatment of AAA617 in early-stage prostate cancer patients to control recurrent tumor from progressing to fatal metastatic disease while preserving quality of life by delaying treatment with androgen deprivation therapy (ADT).
Recruiting
2 awards
Phase 3
6 criteria
Targeted Alpha-Particle Therapy
for Melanoma
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with nivolumab in subjects with unresectable and metastatic melanoma.
Recruiting
1 award
Phase 1 & 2
13 criteria
More about Medhat Osman
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Medhat Osman has experience with
- F18-Fluoride PET/CT
- TC-MDP
- 64Cu-SAR-BBN
- [212Pb]VMT01
- 177Lu-PSMA-617
- 68Ga-PSMA-11
Breakdown of trials Medhat Osman has run
Prostate Cancer
Bone Metastases
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Medhat Osman specialize in?
Medhat Osman focuses on Prostate Cancer and Bone Metastases. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Medhat Osman currently recruiting for clinical trials?
Yes, Medhat Osman is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Medhat Osman has studied deeply?
Yes, Medhat Osman has studied treatments such as F18-Fluoride PET/CT, TC-MDP, 64Cu-SAR-BBN.
What is the best way to schedule an appointment with Medhat Osman?
Apply for one of the trials that Medhat Osman is conducting.
What is the office address of Medhat Osman?
The office of Medhat Osman is located at: Saint Louis University, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Saint Louis University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.